{"id":12626,"date":"2011-03-18T11:01:27","date_gmt":"2011-03-18T15:01:27","guid":{"rendered":"http:\/\/www.thedisciplinedinvestor.com\/blog\/?p=12626"},"modified":"2011-03-18T11:01:27","modified_gmt":"2011-03-18T15:01:27","slug":"march-market-madness-johnson-johnson-jnj","status":"publish","type":"post","link":"https:\/\/thedisciplinedinvestor.com\/blog\/2011\/03\/18\/march-market-madness-johnson-johnson-jnj\/","title":{"rendered":"March Market Madness: Johnson & Johnson (JNJ)"},"content":{"rendered":"

As we mentioned earlier<\/a>, this month we are going to be looking at the stocks that make up the DJIA. . Next up Johnson & Johnson (JNJ).<\/p>\n

These days, even the mightiest<\/em> are falling. When the sellers take hold of the action, this is what happens to a stock’s chart. J&J is another nice income generator as it is passing out 3.71%. But revenue growth has been abysmal. \u00a0 The stock is technically in a bear trend as can be seen by the chart indicators. A good amount of work needs to be done in order to capture the next level for a potential rally point. (above $61 or so).<\/p>\n

Forward earnings estimates are not impressive as they are in the single digits. But this is what can be expected from an old-line blue chip, right?<\/p>\n

With approximately 30% of its revenues generated from Europe and another 15% from Asia, it will have to show some serious product innovations in order to get the stock moving again. Generally, the score tells the story on this one.<\/p>\n

JNJ 20110317<\/a>